The plausible timeline, reconstructed from Lilly's disclosed trial schedule and standard regulatory review windows, looks roughly like this: Q2-Q3 2026: TRIUMPH-1 and TRIUMPH-2 readouts
Intranasal Delivery: Research Considerations Intranasal administration introduces variables that injectable research formats do not share
5, Sept
Chronic muscle spasms differ from ordinary muscle fatigue or delayed onset muscle soreness (DOMS) in two key ways: they occur without provocation (at rest, during sleep, or with minimal movement), and they recur repeatedly in the same muscle groupsthe lower back, neck, calves, hamstrings, or shoulders
Endocrinology 151:14731486 Hegedus L, Moses AC, Zdravkovic M, Le Thi T, Daniels GH (2001) GLP-1 and calcitonin concentration in humans: lack of evidence of calcitonin release from sequential screening in over 5000 subjects with type 2 diabetes or nondiabetic obese subjects treated with the human GLP-1 analog, liraglutide